Steroid after stroke clot removal for anterior circulation large vessel occlusion
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your stroke treatment (clot removal) started within 24 hours of symptom onset.
- The clot was in a major artery in the front part of your brain (internal carotid, M1, or M2 segment).
- Your stroke was severe enough (NIHSS score 6 or higher).
- A CT scan before treatment showed at least some brain tissue was still healthy (ASPECTS score 3 or more).
- The clot removal procedure was successful (blood flow restored to at least a certain level).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a steroid (methylprednisolone) to the standard clot-removal procedure can improve recovery in people with a severe, large stroke. It aims to reduce brain swelling and improve outcomes after the procedure.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests whether butylphthalide, given after a procedure to remove a blood clot from the brain, can help reduce dangerous brain swelling. If you've had a severe stroke and recently had a clot-removal procedure, this drug might improve your recovery.
This trial tests whether giving albumin, a protein naturally found in blood, can improve recovery after a large artery stroke when given along with a procedure to remove the clot. It's for people aged 18-80 who have a stroke from a blockage in the front part of the brain and can get treatment within 24 hours.
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.